31.Issue 10 october 26 - INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES

Volume : 13, Issue : 10, October – 2026

Title:

FORMULATION AND EVALUATION OF MESALAMINE TABLETS FOR COLON DRUG DELIVERY SYSTEMS

Authors :

Raghvendra Singh Yadav*, Dr. Madhusudhan Reddy A

Abstract :

Objective of the current study is to develop colon targeted drug delivery systems for Mesalamine. Eudragit S-100 and Ethyl cellulose is used as polymers in this drug delivery system. The colon targeted tablet was prepared by direct compression technique. Study of the Preformulation characteristics and FTIR studies indicates that there was no interaction between Mesalamine and excipients used. The formulated tablets were tested for both pre-compression parameters and post compression parameters as per requirements of standards. Pre-compression parameters such as bulk density, tapped density, compressibility index, Hausner’s ratio and compressibility index. The results obtained indicate that it has good flow property for direct compression. From among the entire batches, formulation F4 showed 98.90% drug release at 24 hrs. Since it provide greater protection to the core under acidic condition while at the same time show the fastest drug release under intestinal pH. So the trial F4 was considered as best formulation.
Keywords: Mesalamine, Eudragit S-100, Ethyl cellulose, and colon targeted drug delivery systems.

Cite This Article:

Please cite this article in press Raghvendra Singh Yadav et al., Formulation And Evaluation Of Mesalamine Tablets For Colon Drug Delivery Systems.,. Indo Am. J. P. Sci, 2026; 13(10).

REFERENCES:

1. Ansel H, Allen L and Jr. Popovich N. Ansel’s Pharmaceutical Dosage Forms and Drug delivery systems, Baltimore, Md: Lippincott Williams & Wilkins. 8th edition, 2004; p.g 260- 268.
2. Leon Lachmann, Herbert A. Liberman, Joseph L Kanig. The Theory and Practice of Industrial Pharmacy.Varghese publishing House,Bombay, 3rd edition, 1998: p.g. 171, 201- 213, 285-286, 293, 313-314, 400-456.
3. Chien Y.W. Novel Drug Delivery Systems. Revised and expanded, 2nd edition: 1992: p.g 1-2, 139-140.
4. Mehta R.M. Pharmaceutics-1.Vallabh Prakashan, 3rd Edition New Delhi: 2002: p.g. 238-239.
5. Indian pharmacopoeia. The Indian Pharmacopoeia Commission.Ghaziabad: 2007 Vol.2 p.g 662.
6. Debjit Bhowmik. Tablet manufacturing processs and defects of tablets, Elixir Pharmacy 70 (2014) p.g. 24368-24374.
7. Leon Lachmann, Herbert A. Lieberman, Joseph L. Kanig, The Theory and Practice of Industrial Pharmacy, New Delhi,CBS publishers, 4th edition,2006: p.g. 293-303.
8. David Jones, Pharmaceutics Dosage form and Design,. Pharmaceutical Press London, Chicago, 2008, 1st edition p.g: 227.
9. Gilbert.S.Banker, Christopher. T.Rhodes, Modern Pharmaceutics, 4th edition, NewYork. Basel, 1980, p.g:17.
10. Lachman.L, Liberman H.A, Joseph L Kanig. The Theory and Practice of Industrial pharmacy. Varghese publishing house, New Delhi, 3rdedition, 1989; p.g. 331-332.
11. James.W, Linda A.F. Aqueous Polymeric Coating for Pharmaceutical Dosage forms. Taylor and Francis, p.g.327.
12. Alford N Martin, Patrick J. Sinko. Martin’s Physical pharmacy and pharmaceutical sciences, Lippincott Williams & Wilkins. 6th edition 2006.p.g 302
13. Lachman.L, Lieberman H.A, Joseph L Kanig. The Theory and Practice of Industrial Pharmacy, Varghese publishing house, 3rd edition, 1990; p.g 346.
14. Sayed I. Abdel-Rahman, Gamal M.M, El-Badry M, Preparation and Comparative Evaluation of Sustained Release Metoclopramide Hydrochloride Matrix Tablets, Saudi Pharmaceutical Journal ,2009 ; 17: p.g 283-288.
15. Chandran S, Laila F.A and Mantha N, Design and Evaluation of Ethyl Cellulose Based Matrix Tablets of Ibuprofen with pH Modulated Release Kinetics, Indian Journal of Pharmaceutical Sciences, September-October 2008.
16. Gothi G.D, Parinh B.N, Patel T.D, Prajapati S.T, Patel D.M, Patel C.N, Journal of Global Pharma Technology, 2010; 2(2):p.g 69-74.
17. Basak S.C, Reddy J.B.M, and Lucas Mani K.P. Indian Journal of Pharmaceutical Sciences, September-October 2006.
18. Varshosaz J, Tavakoli .N and Kheirolahi. A.A.P.S PharmSciTech, 2006; 7(1).
19. Raghvengra Rao N.G, Gandhi S, and Patel T. International Journal of Pharmacy and Pharmaceutical Sciences, 2009; 1(1).
20. Shivhare U.D, Adhao N.D, Dr. Bhusari K.P, Dr. Mathur V.B and Ambulkar U.D. International Journal of Pharmacy and Pharmaceutical Sciences, 2009; 1(2).
21. Vyas S.P, Khar R.K. Controlled Drug Delivery: Concepts and Advances. 1st edition. Vallabh Prakashan, 2002:p.g.156-189.
22. Brahmankar H.A, Jaiswal S.B, Biopharmaceutics and Pharmacokinetics a Treatise, Vallabh Prakashan, 2000, p.g 348-357 and 337.
23. Wani M.S, Controlled Release System- A Review, 2008, 6 (1), www.pharmainfo.net/review.
24. Philip A.K, Dabas S, Pathak K. Optimized Prodrug Approach: A means for achieving enhanced Anti-inflammatory Potential in Experimentally Induced Colitis. Journal of Drug Target 2009; p.g 17:235-241.
25. Oluwatoyin A.O, John T.F. In vitro evaluation of Khaya and Albizia gums as Compression Coating for Drug Targeting to the Colon. Journal of Pharm Pharmacol 2005; 57:p.g. 63-168.
26. Akala E.O, Elekwachi O, Chase V, Johnson H, Lazarre M, Scott K. Organic Redox-initiate, Polymerization Process for the Fabrication of Hydrogels for Colon-specific Drug Delivery. Ind Pharm. 2003; 29(4): p.g 375-386.
27. Chourasia M.K, Jain S.K. Pharmaceutical Approaches to Colon Targeted Drug Delivery Systems. Journal of Pharmaceutical Science 2003; 6: p.g 33-66.
28. Wood E, Wilson C.G, Hardy J.G. The spreading of foam and solution enemas. International Journal of Pharmacy 1985; 25:p.g 191-197.
29. Singh N, Khanna R.C. Colon targeted drug delivery systems – A Potential Approach. The Pharma journal. Vol. 1 No. 1 2012.
30. Quresh Altamash M, Momin Munira, Rathod Sudha, Dev Asish, Kute Chaitrali. Colon targeted drug delivery system: A review on current approaches. Indian Journal of Pharmaceutical and Biological Research. 2013; 1(4):p.g 130-147.